Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Ocular Therapeutix (OCUL) has a market cap of $1.15 billion USD. According to our data, Ocular Therapeutix is ranked No.4795 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $1.15 B |
-14.07%
|
| Dec 31, 2024 | $1.34 B |
91.48%
|
| Dec 29, 2023 | $0.70 B |
58.72%
|
| Dec 30, 2022 | $0.44 B |
-59.68%
|
| Dec 31, 2021 | $1.10 B |
-66.33%
|
| Dec 31, 2020 | $3.25 B |
424.05%
|
| Dec 31, 2019 | $0.62 B |
-0.75%
|
| Dec 31, 2018 | $0.63 B |
-10.56%
|
| Dec 29, 2017 | $0.70 B |
-46.83%
|
| Dec 30, 2016 | $1.32 B |
-10.67%
|
| Dec 31, 2015 | $1.47 B |
-60.16%
|
| Dec 31, 2014 | $3.70 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Alcon
ALC
|
$45.67 B |
0.453 B
|
Switzerland
|
 Bausch Health
BHC
|
$1.68 B |
13.412 M
|
Canada
|
 Kala Pharmaceuticals
KALA
|
$22.71 M |
-0.065 M
|
USA
|
 Clearside Biomedical
CLSD
|
$62.81 M |
-0.602 M
|
USA
|
 EyePoint Pharmaceuticals
EYPT
|
$0.38 B |
-8.247 M
|
USA
|
 Glaukos
GKOS
|
$5.19 B |
-0.152 B
|
USA
|
 Intra-Cellular Therapies
ITCI
|
$14.05 B |
0.000 M
|
USA
|
 Novartis
NVS
|
$218.28 B |
1.163 B
|
Switzerland
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Santen Pharmaceutical
4536.T
|
$3.33 B |
0.127 B
|
Japan
|
 Ginkgo Bioworks
DNA
|
$0.49 B |
0.111 B
|
USA
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
| Market Cap | = | OCUL Stock Price | * | OCUL Shares Outstanding |
| = | $7.26 | * | 0.16 B | |
| = | $1.15 B |